Search results

Evidence-based recommendations on cabazitaxel (Jevtana) for people with prostate cancer that has come back after it was treated with docetaxel.

Result type

Technology appraisal guidance

Last updated

24 August 2016

Evidence-based recommendations on fostamatinib (Tavlesse) for chronic refractory chronic immune thrombocytopenia in adults.

Result type

Technology appraisal guidance

Published

19 October 2022

Evidence-based recommendations on abiraterone (Zytiga) for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated in adults.

Result type

Technology appraisal guidance

Last updated

27 July 2016

Evidence-based recommendations on abiraterone (Zytiga) for newly diagnosed high-risk hormone-sensitive metastatic prostate cancer in adults.

Result type

Technology appraisal guidance

Published

18 August 2021

NG130/4 Question What is the clinical and cost effectiveness of prednisolone compared with aminosalicylates for the induction of...

Result type

Research recommendation

Published

25 October 2019

Evidence-based recommendations on obinutuzumab (Gazyvaro) for untreated advanced follicular lymphoma in adults.

Result type

Technology appraisal guidance

Published

21 March 2018

Evidence-based recommendations on bortezomib (Velcade) and thalidomide (Thalidomide Celgene) for treating multiple myeloma in adults.

Result type

Technology appraisal guidance

Published

27 July 2011

NG130/5 Question What is the clinical and cost effectiveness of prednisolone plus an aminosalicylate compared with beclometasone plus an...

Result type

Research recommendation

Published

25 October 2019

This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer.

Result type

NICE guideline

Last updated

26 July 2019

Evidence-based recommendations on lenalidomide (Revlimid) plus dexamethasone for multiple myeloma after 1 treatment with bortezomib in adults.

Result type

Technology appraisal guidance

Published

26 June 2019

NG130/3 Question What is the clinical and cost effectiveness of prednisolone, budesonide, and beclometasone in addition to...

Result type

Research recommendation

Published

25 October 2019

Evidence-based recommendations on rituximab for treating relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma in adults.

Result type

Technology appraisal guidance

Published

27 February 2008

adjuvant luteal phase support treatments such as low-dose aspirin, heparin, prednisolone, immunoglobulins and/or fat emulsions. Any...

Result type

Research recommendation

Published

9 June 2015

This guideline sets out an antimicrobial prescribing strategy for insect and spider bites and stings in adults, young people and children aged 72 hours and over, including those that occurred while travelling outside the UK. It aims to limit antibiotic use and reduce antibiotic resistance.

Result type

Antimicrobial prescribing guideline

Published

22 September 2020

Evidence-based recommendations on lenalidomide (Revlimid) with rituximab for previously treated follicular lymphoma (grade 1 to 3A) in adults.

Result type

Technology appraisal guidance

Published

7 April 2020